Abstract

Novel drugs for methicillin-resistant Staphylococcus aureus (MRSA) hospital- and community-acquired infections are needed because of the emergence of resistance against antibiotics. In this study, methanolic and aqueous extracts of Berberis hispanica, Crataegus oxyacantha, Cistus salviifolius, Ephedra altissima, and Lavandula dentata selected from an ethnopharmacological study to treat skin infections in Sefrou city (Center of Morocco) were tested for their antistaphylococcal activity against strains often involved in cutaneous disorders: two methicillin-resistant Staphylococcus aureus strains and one strain of Staphylococcus epidermidis using the well-diffusion assay, while the agar macrodilution method was used to determine the minimal inhibitory concentrations. The total phenolic compounds and flavonoid contents of all tested extracts were also evaluated. Three of the five methanolic extracts showed an important antibacterial activity. Berberis hispanica extract was the most active with a minimal inhibitory concentration of 04.00 mg/ml against all tested strains, followed by Cistus salviifolius and Crataegus oxyacantha extracts containing the highest amounts of total phenols (133.83 ± 9.03 and 140.67 ± 3.17 μg equivalent of gallic acid/mg of extract). However, the aqueous extracts have not shown any activity against the tested strains. The current data suggested that the most active extracts can be a good source of natural antistaphylococcal compounds and warrants further investigations to isolate bioactive molecules.

Highlights

  • Introduction eGram-positive Staphylococcus aureus is a notorious pathogen responsible for diverse infections ranging from acute diseases such as skin abscesses, impetigo, and furunculosis [1, 2] to severe chronic infections [3, 4]

  • After the treatment failure of penicillins and semisynthetic penicillins, vancomycin has been the agent of choice to treat methicillin-resistant Staphylococcus aureus (MRSA) infections [9]

  • According to the National Committee for Clinical Laboratory Standards (NCCLS), S. epidermidis is susceptible to all antibiotics, except tetracycline and colistin, while S. aureus ATCC 29213 and S. aureus are resistant to

Read more

Summary

Introduction

Gram-positive Staphylococcus aureus is a notorious pathogen responsible for diverse infections ranging from acute diseases such as skin abscesses, impetigo, and furunculosis [1, 2] to severe chronic infections [3, 4]. Toxigenic strains of this pathogen have been responsible for staphylococcalscaled skin syndrome through the diffusion of the exfoliative toxins [5] and for necrotizing pneumonia through the secretion of Panton-Valentine leukocidin pore-forming toxin [6]. Among pathogenic Staphylococcus genus, S. epidermidis bacteria has gained substantial interest since it is the most important cause of nosocomial infections. After the treatment failure of penicillins and semisynthetic penicillins, vancomycin has been the agent of choice to treat methicillin-resistant Staphylococcus aureus (MRSA) infections [9]. Natural substances could constitute a prominent source of new antibacterial molecules knowing that 75% of International Journal of Microbiology

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.